• Pregnenolone Carbonitrile: Advancing Translational Resear...

  2025-10-21

  Pregnenolone Carbonitrile (PCN), a potent rodent PXR agonist, is redefining translational research across xenobiotic metabolism, hepatic fibrosis, and water homeostasis. This thought-leadership article synthesizes emerging mechanistic insights—including the newly elucidated PXR-AVP axis—with actionable strategies for translational researchers. By contextualizing PCN within the competitive landscape and providing evidence-based guidance, we chart a visionary path for leveraging this unique compound in next-generation biomedical discovery.

• Nitrocefin: The Gold Standard Chromogenic Cephalosporin S...

  2025-10-20

  Nitrocefin empowers researchers with rapid, precise, and visually discernible assays for β-lactamase detection and antibiotic resistance profiling. Its vivid colorimetric shift and broad substrate specificity deliver unmatched performance in both mechanistic studies and clinical screening workflows. Harness Nitrocefin’s versatility to streamline β-lactamase inhibitor discovery and deepen insights into emergent resistance mechanisms.

• Nitrocefin: Precision Tools for Decoding β-Lactamase Evol...

  2025-10-19

  Explore how Nitrocefin, a chromogenic cephalosporin substrate, advances β-lactamase detection and antibiotic resistance profiling. This article uniquely delves into evolutionary insights, structure-function relationships, and experimental best practices for multidrug-resistant pathogen research.

• Nitrocefin-Powered Precision: Advancing β-Lactamase Detec...

  2025-10-18

  This thought-leadership article unpacks the mechanistic, experimental, and translational imperatives of using Nitrocefin—a chromogenic cephalosporin substrate—for cutting-edge β-lactamase detection, resistance profiling, and inhibitor screening. By integrating recent biochemical discoveries, strategic assay design guidance, and a critical assessment of the competitive landscape, we provide translational researchers with actionable insights to outpace the evolution of multidrug-resistant pathogens.

• Disulfiram: Proteasome Inhibitor Empowering Cancer Research

  2025-10-17

  Disulfiram, renowned as an anti-alcoholism drug and dopamine β-hydroxylase inhibitor, has emerged as a potent copper-complex proteasome inhibitor driving innovation in cancer and inflammasome research. This article delivers stepwise workflows, advanced protocol enhancements, and expert troubleshooting strategies to maximize Disulfiram’s impact in breast cancer MDA-MB-231 cell research and beyond.

• BGJ398 (NVP-BGJ398): Selective FGFR Inhibition for Oncolo...

  2025-10-16

  BGJ398 (NVP-BGJ398) stands out as a highly selective small molecule FGFR inhibitor, enabling researchers to dissect the roles of FGFR1/2/3 in cancer and developmental biology with precision. This article details experimental workflows, advanced use-cases, and troubleshooting strategies to maximize the impact of BGJ398 in FGFR-driven malignancies research and developmental signaling studies.

• br Conclusion The HT receptor

  2023-07-06

  

  Conclusion The 5-HT receptor family is complex, and one may ask as does Bryan Roth et al. [205] whether this is useless HPK 56 (i.e. too much redundancy) or an embarrassment of the riches (i.e. many potential targets to choose from to affect normal or pathological function); molecular biology ha

• Polyphyllin VII sale br Autophagy in cancer br Phytochemical

  2023-07-05

  

  Autophagy in cancer Phytochemicals as a valuable source of autophagy modulation agents Epidemiological studies demonstrated that there is a strong association between diet and human cancer mortality so that daily consumption of phytochemicals declines the incidence of different types of cancer

• br Current limitations and future directions

  2023-07-05

  

  Current limitations and future directions There are several limitations associated with PET imaging of aromatase using carbon-11 labeled aromatase inhibitors. Due to the very short half-life of carbon 11 (20min), PET studies with currently available, validated tracers can only be performed in med

• In addition to attracting immune cells to the

  2023-07-05

  

  In addition to attracting immune cells to the site of injury, ROS also participate in proliferative responses during compensatory proliferation and regeneration. In Xenopus tadpoles, tail amputation induces sustained production of ROS over the span of regeneration, and decreasing ROS levels, especia

• AR Vs are truncated AR proteins lacking the AR ligand

  2023-07-05

  

  AR-Vs are truncated AR proteins lacking the AR ligand-binding domain (AR-LBD) [6]. While AR-Vs have frequently been detected in CRPC, their expression and functional role in benign prostate tissues and primary prostate cancers is not readily apparent. Structural rearrangements in the AR gene and alt

• AR Vs are truncated AR proteins lacking the AR ligand

  2023-07-05

  

  AR-Vs are truncated AR proteins lacking the AR ligand-binding domain (AR-LBD) [6]. While AR-Vs have frequently been detected in CRPC, their expression and functional role in benign prostate tissues and primary prostate cancers is not readily apparent. Structural rearrangements in the AR gene and alt

• The most common adverse effects were ARIA

  2023-07-05

  

  The most common adverse effects were ARIA, which occurred at higher levels than in any previous anti-Aβ mAb study. ARIA-E was observed at some point during the trial in no participants in the placebo group compared with 1 (3%), 2 (6%), 11 (37%), and 13 (41%) participants receiving 1, 3, 6, and 10 mg

• Aberrant lipid levels are associated with various

  2023-07-05

  

  Aberrant lipid levels are associated with various disorders, including vascular diseases and diabetes. Furthermore, important events support the idea that lipids, especially cholesterol and its derivatives, have a fundamental role in the physiopathology of AD. The DRB is rich in cholesterol, and it

• br Materials and Methods br Results A total of NSCLC

  2023-07-05

  

  Materials and Methods Results A total of 28 NSCLC tumor samples from 26 patients (2 patients with paired tumor samples) were included. According to the initial FISH (Abbott Molecular probes) and IHC results, 13 samples were ALK IHC+FISH+, 5 samples were ALK IHC+FISH−, 2 samples (from the same

11095 records 1/740 page Next 12345 下5页 Last page